Manuel Montero-Odasso, MD, FRCPC, PhD, AGSF, FGSA, FCAHS

Dr. Manuel Montero-Odasso is an internist, geriatrician, and clinician-scientist, and Fellow of the Canadian Academy of Health Sciences. He is Professor at Western University, Canada in the Departments of Medicine (Geriatrics) and Epidemiology and Biostatistics. and holds the Wolf Research Professorship in Aging endowment chair. He is the Director of the Gait & Brain Lab, at Parkwood Institute in London Ontario. He also serves as Past-President of the Canadian Geriatrics Society and chairs the World  Guidelines for Falls Prevention and Management for Older Adults.

He has extensive clinical, teaching, and research expertise in the care of older adults that are vulnerable to falls and cognitive impairment. More specifically, he has been the principal and co-investigator of more than 40 research grants in the field of falls, cognition, gait, and mobility performance, prediction models for dementia, and clinical trials using non -pharmacological interventions to improve cognition and delay dementia. He has been awarded over $16 Million dollars in peer-reviewed funding.

He is a member of the executive and team leader of the Canadian Consortium on Neurodegeneration in Aging (CCNA) where he is co-Principal Investigator in the Canadian Therapeutic Platform for Multidomain Interventions to Prevent Dementia (CAN-Thumbs-UP), where he is leading multi-domain lifestyle interventions clinical trials (SYNERGIC Trials, part of the World Wide Finger Network), to delay dementia in older adults with Mild Cognitive Impairment by using personalized medicine.

He has published over 300 articles (h-index 67, Google Scholar) and is (co)editor / (co)author of over 20 books and book chapters. He serves as Editor-in-Chief of the Neurology Section of the Journal of Geriatrics and holds Associate Editor roles in he Journal of Gerontology Medical Sciences, Journal of Alzheimer’s Disease, the Canadian Geriatrics Journal, and BMC Geriatrics.

He has received several national and international accolades including the American Geriatrics Society New Investigator Award, the Schulich Clinician Scientist Award, the Premier of Ontario Excellence Research Award, and the CIHR New Investigator Award, the Irma Parhad Distinguished Award, among others. He has delivered over 200 keynote addresses. His research impact is further demonstrated by his ranking in the prestigious Stanford University Report as one of the ‘Top 2% world scientists’.

In 2019, he was inducted as one of the “Top 10 Hispanic-Canadian” for his contribution to Medicine and Science.